Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice

[1]  K. Prokai-Tatrai,et al.  Pharmacokinetics and urinary excretion of DMXBA (GTS‐21), a compound enhancing cognition , 1998, Biopharmaceutics & drug disposition.

[2]  G. Rose,et al.  Rats Reared in Social Isolation Show Schizophrenia-Like Changes in Auditory Gating , 1997, Pharmacology Biochemistry and Behavior.

[3]  W. J. Jackson,et al.  Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo , 1997, Pharmacology Biochemistry and Behavior.

[4]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[6]  P. Sanberg,et al.  Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21 , 1995, Brain Research.

[7]  J. Horn,et al.  Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. , 1995, Pharmacology.

[8]  H. Coon,et al.  Schizophrenia and Nicotinic Receptors , 1994, Harvard review of psychiatry.

[9]  D. Woodruff-Pak,et al.  A nicotinic agonist (GTS-21), eyeblink classical conditioning and nicotinic receptor binding in rabbit brain , 1994, Brain Research.

[10]  B. Hunter,et al.  Effects of anabaseine‐related analogs on rat brain nicotinic receptor binding and on avoidance behaviors , 1994 .

[11]  T. Robbins,et al.  Social Isolation in the Rat Produces Developmentally Specific Deficits in Prepulse Inhibition of the Acoustic Startle Response Without Disrupting Latent Inhibition , 1994, Neuropsychopharmacology.

[12]  Trevor W. Robbins,et al.  Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia , 1993, Biological Psychiatry.

[13]  P. Bickford,et al.  Phencyclidine and auditory sensory gating in the hippocampus of the rat , 1992, Neuropharmacology.

[14]  Robert Freedman,et al.  Cholinergic gating of response to auditory stimuli in rat hippocampus , 1992, Brain Research.

[15]  P. Venables Hippocampal Function and Schizophrenia. Experimental Psychological Evidence a , 1992, Annals of the New York Academy of Sciences.

[16]  M. Greeman,et al.  Negative effects of a smoking ban on an inpatient psychiatry service. , 1991, Hospital & community psychiatry.

[17]  Norbert Kathmann,et al.  Sensory gating in normals and schizophrenics: A failure to find strong P50 suppression in normals , 1990, Biological Psychiatry.

[18]  A. C. Collins,et al.  Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists , 1990, Brain Research.

[19]  B. Costall,et al.  5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue , 1989, Nature.

[20]  A. Papanicolaou,et al.  Habituation of auditory event-related potentials: a comparison of self-initiated and automated stimulus trains. , 1987, Electroencephalography and clinical neurophysiology.

[21]  M. Williams,et al.  Nicotinic receptors in mammalian brain , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  R Freedman,et al.  Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.

[23]  J. Wheeler,et al.  Anabaseine: venom alkaloid of aphaenogaster ants. , 1981, Science.

[24]  J. Eccles The Inhibitory Pathways of the Central Nervous System , 1969 .

[25]  W. Wilson,et al.  Auditory habituation at primary cortex as a function of stimulus rate. , 1968, Experimental Neurology.

[26]  Alvaro E. Urrutia,et al.  Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors ha2 , 1997 .

[27]  R. Papke,et al.  Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. , 1995, Molecular pharmacology.

[28]  A. Beaudet,et al.  Cloning and mapping of the mouse alpha 7-neuronal nicotinic acetylcholine receptor. , 1995, Genomics.

[29]  D. Bertrand,et al.  A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. , 1990, Neuron.

[30]  R Freedman,et al.  Neurobiological studies of sensory gating in schizophrenia. , 1987, Schizophrenia bulletin.

[31]  W. Kem,et al.  A study of the occurrence of anabaseine in Paranemertes and other nemertines. , 1971, Toxicon : official journal of the International Society on Toxinology.

[32]  B. C. Abbott,et al.  Isolation and structure of a hoplonemertine toxin. , 1971, Toxicon : official journal of the International Society on Toxinology.

[33]  P. Venables,et al.  INPUT DYSFUNCTION IN SCHIZOPHRENIA. , 1964, Progress in experimental personality research.